Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 7/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 2/20 | 0.49 |
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.49 |
| ▸ | TACR1 | P25103 | 2/20 | 0.49 |
| ▸ | GHSR | Q92847 | 1/20 | 0.48 |
| ▸ | CCKBR | P32239 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23700467 | 0.96 | DPP3 (0.52) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23700466 | 0.96 | DPP3 (0.52) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23710034 | 0.94 | KISS1R (0.50) | KISS1ROPRM1TACR2DPP3TACR1 | |
| SCHEMBL30466184 | 0.94 | KISS1R (0.50) | KISS1ROPRM1TACR2DPP3TACR1 | |
| SCHEMBL23710110 | 0.94 | KISS1R (0.50) | KISS1ROPRM1TACR2DPP3TACR1 | |
| SCHEMBL23700403 | 0.93 | KISS1R (0.51) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23700406 | 0.93 | KISS1R (0.51) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23700273 | 0.90 | DPP3 (0.53) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23700272 | 0.90 | DPP3 (0.53) | KISS1ROPRM1DPP3TACR1CCKBR | |
| SCHEMBL23710114 | 0.90 | KISS1R (0.47) | KISS1ROPRM1TACR2DPP3TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296955-A1 | PIN1 TARGETING COMPOUNDS AND DEGRADERS AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-25 | — | — | US | disclosed |
| WO-2025111511-A2 | REVERSIBLY REACTIVE AFFINITY SELECTION MASS SPECTROMETRY AND USES THEREOF | CALICO LIFE SCIENCES LLC (US) | 2025-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296955-A1 | PIN1 TARGETING COMPOUNDS AND DEGRADERS AND METHODS THEREOF | PIN1, MDM2, XIAP | KISS1R 4247/4885OPRM1 4678/4885TACR2 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.